IMPSPEX Diagnostics secures €1.5m in EU funding to fight global infections
IMSPEX Diagnostics has secured €1.5m in EU funding to lead a European project to revolutionise the way respiratory illnesses are diagnosed (Welsh Government, 2017). The investment will see IMSPEX Diagnostics, which is based in Abercynon, team up with leading manufacturers and clinical trial specialists in Germany and Ireland and with the University of Warwick and … Continue reading IMPSPEX Diagnostics secures €1.5m in EU funding to fight global infections
First patient treated with Creo Medical device
The first patient has been treated with a device made by Chepstow-based surgical technology company Creo Medical (MediWales, 2017). The AIM-listed company’s Speedboat device has been used by Professor Brian Saunders at St Mark’s Hospital in London to treat a patient with a large pre-cancerous lesion in the gastrointestinal tract. Craig Gulliford, chief executive of … Continue reading First patient treated with Creo Medical device
ReNeuron expecting “significant clinical milestones”
Losses have widened at ReNeuron but the Bridgend-based cell therapy company is expected to achieve “significant clinical milestones” over the next three years (Insider Media, 2017). The AIM listed business reported a pre-tax loss of £18.2m in its results for the year ending March 31st 2017, up from £12.8m in 2015/16. Royalty income was £46,000, … Continue reading ReNeuron expecting “significant clinical milestones”
UK’s first artificial heart pump due to begin trials in 2018
Scientists have said the UK’s first artificial heart pump has moved a step closer to being used on patients (BBC News, 2017). The heart pump has been developed at Swansea University’s Institute of Life Science 2 by Calon Cardio, and clinical trials are due to begin in late 2018 with the aim of a full … Continue reading UK’s first artificial heart pump due to begin trials in 2018
Cardiff set to become the home of a new cannabis research facility
A groundbreaking research facility which will study the medical benefits of cannabis is set to be unveiled this summer (WalesOnline, 2017). MediPen, which launched a cannabis-based vaporiser last year, says it will run a “strenuous” course of clinical trials into the medicinal applications of cannabis from its 1,800sq ft site in Cardiff. The company says … Continue reading Cardiff set to become the home of a new cannabis research facility
Anti-venom from Wales will soon help snake bite victims in Africa
Snake bite victims in Europe and Africa will soon benefit from anti-venoms produced in Carmarthenshire (WalesOnline, 2017). MicroPharm develops immunotherapy products to target infectious diseases and acute toxic conditions. It produces two anti-venoms for the treatment of snake bites from the European common adder and the carpet viper in West Africa. Its planned £2m expansion, … Continue reading Anti-venom from Wales will soon help snake bite victims in Africa
Advanced Medical Simulation Online moves into Cardiff Medicentre
A company that provides specialist learning and training to the medical profession has taken up office space at leading medtech and biotech incubator, Cardiff Medicentre (MediWales, 2017). Advanced Medical Simulation Online (AMSO) becomes the eighteenth tenant of Cardiff Medicentre, which is located in the grounds of the University Hospital of Wales. Dedicated to supporting early … Continue reading Advanced Medical Simulation Online moves into Cardiff Medicentre
Frontier Medical adds to its pressure ulcer prevention range
Specialist medical device manufacturer Frontier Medical Group has launched a new range of pressure redistribution pads (MediWales, 2017). Designed to complement the company’s existing portfolio, which includes the Repose range of pressure area care products and Toto, an automated patient turning platform, Dermis Plus offers a solution for localised pressure redistribution and the management of … Continue reading Frontier Medical adds to its pressure ulcer prevention range
ConvaTec shares to be sold in £800m deal
Nordic Capital and Avista are raising more than £800m by selling significant stakes in medical products and technology company ConvaTec (Insider Media, 2017). The businesses have agreed to sell two hundred and fifty million shares in ConvaTec to institutional investors at a price of 322p per share, raising gross proceeds of £805m, through an accelerated … Continue reading ConvaTec shares to be sold in £800m deal
BBI Solutions increases capacity for cell culture native human transferrin production
BBI Solutions has invested in its facilities and resources to increase the capacity of cell culture transferrin production by up to 40% (Pharma Integrates, 2017). Stephane Argivier, BBI’s Director of Product Management, said “Demand for our cell culture grade transferrin was growing at such a rate that we had reached our full capacity. In response … Continue reading BBI Solutions increases capacity for cell culture native human transferrin production
